-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Monday's Pre-Market Session
Share
Listen to the news

Gainers

  • Universe Pharmaceuticals (NASDAQ:UPC) stock moved upwards by 159.6% to $7.68 during Monday's pre-market session. The company's market cap stands at $1.9 million.
  • Decoy Therapeutics (NASDAQ:DCOY) stock moved upwards by 117.45% to $12.0. The company's market cap stands at $2.9 million.
  • Precision Optics Corp (NASDAQ:POCI) shares rose 17.39% to $6.21. The market value of their outstanding shares is at $57.8 million.
  • Tvardi Therapeutics (NASDAQ:TVRD) shares rose 16.0% to $1.74. The market value of their outstanding shares is at $14.0 million.
  • Tevogen Bio Holdings (NASDAQ:TVGN) shares rose 14.28% to $8.0. The company's market cap stands at $29.5 million.
  • Alaunos Therapeutics (NASDAQ:TCRT) shares moved upwards by 12.98% to $2.35. The market value of their outstanding shares is at $5.0 million.

Losers

  • Jupiter Neurosciences (NASDAQ:JUNS) stock declined by 23.4% to $0.21 during Monday's pre-market session. The market value of their outstanding shares is at $13.5 million.
  • Larimar Therapeutics (NASDAQ:LRMR) shares declined by 21.86% to $2.86. The company's market cap stands at $380.2 million.
  • Shuttle Pharmaceuticals (NASDAQ:SHPH) shares fell 12.94% to $3.5. The market value of their outstanding shares is at $2.3 million.
  • Pulmatrix (NASDAQ:PULM) stock fell 12.2% to $1.44. The market value of their outstanding shares is at $5.9 million.
  • INVO Fertility (NASDAQ:IVF) shares declined by 10.21% to $2.2. The company's market cap stands at $4.3 million.
  • Biodexa Pharmaceuticals (NASDAQ:BDRX) stock fell 9.94% to $2.63. The company's market cap stands at $2.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending